Yale, Jean-François http://orcid.org/0000-0002-7833-9050
Roborel de Climens, Aude http://orcid.org/0000-0002-5065-2010
Aggarwal, Naresh
Dex, Terry
Gerstein, Hertzel C. http://orcid.org/0000-0001-8072-2836
Harris, Stewart http://orcid.org/0000-0002-1794-6551
Hramiak, Irene http://orcid.org/0000-0002-3032-5338
Stewart, John
Leiter, Lawrence A. http://orcid.org/0000-0002-1040-6229
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers
https://doi.org/10.1007/s13300-022-01353-6
95-LB: LixilanONE CAN: Randomized Trial Comparing a Daily vs. Weekly Titration Algorithm for Switching from Basal Insulin to iGlarLixi Fixed-Ratio Combination in People with T2DM in Canada
https://doi.org/10.2337/db21-95-lb
Funding for this research was provided by:
Sanofi
Article History
Received: 11 August 2022
Accepted: 29 November 2022
First Online: 27 December 2022
Change Date: 14 January 2023
Change Type: Update
Change Details: The original article was revised due to update in second author name.